LY 355703

Known as: LY-355703, LY355703 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2006
012319982006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
LY355703 is a synthetic product structurally related to the cryptophycin family isolated from the blue-green algae, which exerts… (More)
Is this relevant?
2004
2004
Cryptophycin 52 (LY355703) is a potent antiproliferative analogue of the marine natural product cryptophycin 1. It has been shown… (More)
  • figure 1
  • figure 2
  • table 1
  • table 1
  • figure 3
Is this relevant?
2003
2003
A highly enantioselective and convergent synthesis of cryptophycin 52 (2), an exceedingly potent cytotoxic agent, is described… (More)
Is this relevant?
2002
2002
LY355703 is a synthetic derivative of the marine cryptophycins, cytotoxic agents which induce mitotic arrest by binding at the… (More)
Is this relevant?
2002
2002
We assessed the ability of cryptophycin 52 (LY355703), a novel antimicrotubule, to induce growth arrest and apoptosis in prostate… (More)
  • figure 1
  • figure 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2002
2002
The cryptophycin analogue LY355703 is a potent inhibitor of microtubule polymerization that displays in vitro and in vivo… (More)
  • figure 1
  • table 2
  • table 1
  • table 3
  • figure 2
Is this relevant?
2000
2000
Cryptophycin-52 (LY355703) is currently undergoing clinical evaluation for cancer chemotherapy. It is a potent suppressor of… (More)
Is this relevant?
2000
2000
Introduction/Purpose: Cryptophycins are a family of antitubulin antitumor agents. A synthetic cryptophycin derivative (LY355703… (More)
Is this relevant?
1998
1998
Cryptophycin-52 (LY355703) is a new synthetic member of the cryptophycin family of antimitotic antitumor agents that is currently… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?